1,280
Views
5
CrossRef citations to date
0
Altmetric
Short Communication

Protective effect of Pycnogenol on cisplatin-induced ototoxicity in rats

, , , , , , , & show all
Pages 2777-2781 | Received 14 Oct 2015, Accepted 07 Apr 2016, Published online: 09 May 2016

References

  • Alam SA, Ikeda K, Oshima T, Suzuki M, Kawase T, Kikuchi T, Takasaka T. 2000. Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res. 141:28–38.
  • Chirtes F, Albu S. 2014. Prevention and restoration of hearing loss associated with the use of cisplatin. Biomed Res Int. 2014:925485.
  • Cho SI, Lee JH, Park JH, Do NY. 2014. Protective effect of (−)-epigallocatechin-3-gallate against cisplatin-induced ototoxicity. J Laryngol Otol. 15:1–6.
  • Deavall DG, Martin EA, Horner JM, Roberts R. 2012. Drug-induced oxidative stress and toxicity. J Toxicol. 2012:645460.
  • Fetoni AR, Quaranta N, Marchese R, Cadoni G, Paludetti G, Sergi B. 2004. The protective role of tiopronin in cisplatin ototoxicity in Wistar rats. Int J Audiol. 43:465–470.
  • Harrison RT, DeBacker JR, Bielefeld EC. 2015. A low-dose regimen of cisplatin before high-dose cisplatin potentiates ototoxicity. Laryngoscope 125:E78–E83.
  • Kim YJ, Kang KS, Yokozawa T. 2008. The anti-melanogenic effect of pycnogenol by its anti-oxidative actions. Food Chem Toxicol. 46:2466–2471.
  • Labbé D, Teranishi M, Hess A, Bloch W, Michel O. 2005. Activation of caspase-3 is associated with oxidative stress in the hydropic guinea pig cochlea. Hear Res. 202:21–27.
  • Lee IC, Kim SH, Shin IS, Moon C, Park SH, Kim SH, Park SC, Kim HC, Kim JC. 2012. Protective effects of pine bark extract on hexavalent chromium-induced dermatotoxicity in rats. Phytother Res. 26:1534–1540.
  • Luzzi R, Belcaro G, Hu S, Dugall M, Hosoi M, Cacchio M, Ippolito E, Corsi M. 2014. Improvement in symptoms and cochlear flow with pycnogenol in patients with Meniere’s disease and tinnitus. Minerva Med. 105:245–254.
  • Olgun Y, Kırkım G, Kolatan E, Kiray M, Bagriyanik A, Olgun A, Kizmazoglu DC, Elidokuz H, Serbetcioglu B, Altun Z, et al. 2014. Friend or foe? Effect of oral resveratrol on cisplatin ototoxicity. Laryngoscope. 124:760–766.
  • Packer L, Rimbach G, Virgili F. 1999. Antioxidant activity and biologic properties of a procyanidin-rich extract from pine (Pinus maritima) bark, Pycnogenol. Free Radic Biol Med. 27:704–724.
  • Parveen K, Khan MR, Siddiqui WA. 2009. Pycnogenol prevents potassium dichromate K2Cr2O7-induced oxidative damage and nephrotoxicity in rats. Chem Biol Interact. 18:343–350.
  • Rabik CA, Dolan ME. 2007. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat Rev. 33:9–23.
  • Ravi R, Somani SM, Rybak LP. 1995. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol. 76:386–394.
  • Rybak LP. 2007. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr Opin Otolaryngol Head Neck Surg. 15:364–369.
  • Siler-Marsiglio KI, Shaw G, Heaton MB. 2004. Pycnogenol and vitamin E inhibit ethanol-induced apoptosis in rat cerebellar granule cells. J Neurobiol. 59:261–271.
  • Taner G, Aydın S, Bacanlı M, Sarigol Z, Sahin T, Basaran AA, Basaran N. 2014. Modulating effects of pycnogenol® on oxidative stress and DNA damage induced by sepsis in rats. Phytother Res. 28:1692–1700.
  • Watanabe K, Hess A, Michel O, Yagi T. 2000. Nitric oxide synthase inhibitor reduces the apoptotic change in the cisplatin-treated cochlea of guinea pigs. Anti-Cancer Drugs. 11:731–735.
  • Yang YS, Ahn TH, Lee JC, Moon CJ, Kim SH, Jun W, Park SC, Kim HC, Kim JC. 2008. Protective effects of Pycnogenol on carbon tetrachloride-induced hepatotoxicity in Sprague-Dawley rats. Food Chem Toxicol. 46:380–387.
  • Yazici ZM, Meric A, Midi A, Arinc YV, Kahya V, Hafiz G. 2012. Reduction of cisplatin ototoxicity in rats by oral administration of pomegranate extract. Eur Arch Otorhinolaryngol. 269:45–52.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.